Ravindra Ganesh to Male
This is a "connection" page, showing publications Ravindra Ganesh has written about Male.
Connection Strength
0.042
-
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 10 28; 224(8):1278-1286.
Score: 0.013
-
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
Score: 0.013
-
A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities. J Am Geriatr Soc. 2021 04; 69(4):868-873.
Score: 0.013
-
Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 03; 96(3):601-618.
Score: 0.003